LIFECORE BIOMEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.28 USD | -4.41% |
|
-1.72% | +1.45% |
| 19/04 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
| 01/04 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 201M | - | - | ||||
| 695B | ||||||
| 568B | ||||||
| 361B | ||||||
| 330B | ||||||
| 283B |
